Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages

NCT03424226 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03424226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03424226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
August 4, 2018
Completion date
September 30, 2018
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mountain sickness